oral glp-1 medications approved In a major milestone for obesity care, the FDA has Wegovy® as the first receptor agonist for chronic weight management in adults with obesity or overweight and related conditions Is the Wegovy® Pill &

: Wegovy an adjunct to diet and exercise to reduce body weight an maintain weight reduction to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight

Most adults (70%) who have taken GLP-1 drugs say their insurance covered at least a part of the cost of these drugs, including about half (48%) who say their insurance covered part of the cost of these drugs and about one in five (22%) who say their insurance covered all of the cost

In the months since we launched the GLP-1 Supply Tracker, theres been ongoing news and updates about the GLP-1 shortages

P., Gause-Nilsson, I., Persson, A